# Progress Note 07 — Annual Wellness Visit, Initial

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Dwight D. Eisenhower (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET015-SYN-TD
- Date: 1956-10-19
- Fictional facility: St. Posthumous Health Center
- Fictional author: Russell Okonkwo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Annual Wellness Visit, Initial
- Services: HCPCS G0438 (initial annual wellness visit, first eligible after twelve months of Medicare Part B) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Initial annual wellness visit; no new complaints. **S**

## History of present illness

Mr. Eisenhower comes for his first annual wellness visit, three weeks after his one-year coronary review, at which ticagrelor was stopped and he continued aspirin alone. He completed the health risk assessment before the visit. He has had no chest pain, breathlessness, palpitations, or further nosebleeds, and has not needed nitroglycerin. He works full time, travels often, walks most days, and plays golf twice a week. He takes his medicines from a weekly organizer and has added no over-the-counter medicines or supplements. He has had no falls. **S**

| Element | Detail |
|---|---|
| Visit | Initial annual wellness visit |
| Cardiac symptoms | None; no nitroglycerin use |
| Safety events | No falls; no further nosebleeds |
| Medicines | Adherent with a weekly organizer; no new over-the-counter medicines or supplements |
| Active conditions | Coronary artery disease after myocardial infarction, hyperlipidemia, and hypertension, all controlled |
| Functional status | Independent in all activities and instrumental activities of daily living; working full time |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Very good, and better than a year ago |
| Psychosocial | Married; strong family and work supports; work stress high but manageable; sleeps about seven hours |
| Behavioral | Former heavy cigarette smoker, quit about seven years ago, no relapse; one or two drinks a week; walks most days and plays golf twice a week; Mediterranean-style diet |
| Activities of daily living | Independent in bathing, dressing, eating, toileting, and transfers |
| Instrumental activities of daily living | Manages his own medicines, finances, and travel |
| Home safety | Smoke detectors working; seat belt always; firearms not kept at home |
| Hearing and vision | No hearing concerns; reading glasses; last eye examination more than two years ago |
| Bladder | No urinary symptoms |
| Memory | No concerns from him or his family |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; good energy; no fever |
| Eyes | Negative | No change in vision with reading glasses |
| Ears, nose, mouth, and throat | Negative | No hearing loss or further nosebleeds |
| Cardiovascular | Negative | No chest pain, palpitations, orthopnea, or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No black stools or reflux |
| Genitourinary | Negative | No hesitancy, nocturia beyond once, or hematuria |
| Musculoskeletal | Negative | No joint pain or falls |
| Integumentary | Negative | No new or changing skin lesions |
| Neurological | Negative | No weakness, numbness, speech change, or memory change |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |
| Hematologic | Negative | Less bruising since ticagrelor stopped |

12 systems reviewed. **S**

## Current medications

- Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily **S**
- Atorvastatin 80 mg oral tablet, one tablet by mouth daily **S**
- Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth daily **S**
- Lisinopril 10 mg oral tablet, one tablet by mouth daily **S**
- Ezetimibe 10 mg oral tablet, one tablet by mouth daily **S**
- Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tablet **S**

## Allergies

- No known allergy **S**

## Objective

BP 126/76 mmHg; pulse 60 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 77.2 kg; BMI 24.4 kg/m². All vital signs are synthetic.

PHQ-2: 0; Mini-Cog: 5; AUDIT-C: 1. All results are synthetic.

## Change since baseline

- PHQ-2: 1 at baseline, 0 at this visit **S**
- AUDIT-C: 1 at baseline, 1 at this visit **S**

## Immunizations given today

- High-dose influenza vaccine, 1956-1957 season **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well-appearing; weight 77.2 kg, stable |
| Eyes | Pupils equal and reactive; near vision 20/25 with reading glasses |
| Ears | Canals clear; whispered-voice test passed on both sides |
| Neck | No carotid bruits; jugular venous pressure not raised |
| Cardiovascular | Regular rhythm; no murmur or gallop; pedal pulses present; no edema |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; no pulsatile mass or aortic bruit |
| Musculoskeletal | Timed Up and Go 8 seconds with a steady gait |
| Neurological | Oriented; Mini-Cog 5 of 5 (recall 3 of 3, clock normal) |
| Psychiatric | Euthymic, direct, and engaged |
| Skin | Sun damage on the scalp and forearms; no suspicious lesions |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Initial annual wellness visit completed**. Health risk assessment reviewed, personalized prevention plan written, and a copy given. Depression, alcohol, cognitive, and fall-risk screens are negative. **S**
   - Subsequent annual wellness visit in one year.
2. **Coronary artery disease after myocardial infarction** (I25.10). No angina. Aspirin alone since the one-year review, with atorvastatin, ezetimibe, metoprolol, and lisinopril. **S**
   - No change; next coronary review in about six months with a lipid panel and basic metabolic panel.
3. **Essential hypertension** (I10). Blood pressure 126/76 mmHg, at goal. **S**
   - No change.
4. **Former heavy cigarette smoker** (Z87.891). Abstinent about seven years. Eligible for one-time abdominal aortic aneurysm screening and for yearly lung cancer screening. **S**
   - Abdominal aortic ultrasound and low-dose chest CT ordered after shared decision-making.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, 1956-1957 | Completed today | High-dose vaccine given today |
| COVID-19 vaccine, 1956-1957 | Due | Recommended with coronary disease; he plans to get it at his pharmacy |
| Pneumococcal vaccine | Up to date | PCV20 given in January; no further doses needed |
| RSV vaccine | Up to date | Single dose given at the one-year review three weeks ago |
| Recombinant zoster vaccine | Up to date | Two-dose series completed about three and a half years ago |
| Tetanus booster | Up to date | Tdap about seven years ago; next due in about three years |
| Abdominal aortic aneurysm screening | Ordered | One-time ultrasound for a man aged 65 to 75 who has ever smoked |
| Lung cancer screening | Ordered | Age 66, well over 20 pack-years, quit about seven years ago. After shared decision-making about benefits, false positives, and radiation, he chose yearly low-dose CT; first scan ordered |
| Colorectal cancer screening | Up to date | Normal colonoscopy five years ago; next due in five years |
| Prostate cancer screening | Declined | Shared decision-making about the small benefit and the risks of overdiagnosis; he chose not to have PSA testing |
| Hepatitis C screening | Up to date | One-time screen negative in the past |
| Cholesterol and diabetes screening | Up to date | LDL cholesterol 49 mg/dL three weeks ago; HbA1c 5.6% in January, due again in January |
| Depression screening | Completed today | PHQ-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 1 |
| Cognitive assessment | Completed today | Mini-Cog 5 of 5 |
| Falls and functional assessment | Completed today | No falls; Timed Up and Go 8 seconds |
| Tobacco use | Completed today | Abstinent; relapse-prevention advice given |
| Eye examination | Due | More than two years since his last examination; he will book with his optometrist |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He has named a health care agent and completed a written health care directive; a copy is now in the chart. He wants full treatment, including coronary procedures and intensive care, for any condition from which he could return to an active life. He would not want prolonged life support if he were unlikely to recover the ability to think and communicate. He will review these wishes with his agent. **S**

## Guideline basis

- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023), American Heart Association and American College of Cardiology
- Medicare Wellness Visits (Medicare Learning Network) (2026), Centers for Medicare & Medicaid Services
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge

## Follow-up

- Abdominal aortic ultrasound and low-dose chest CT ordered. Coronary review with laboratory tests in about six months. Subsequent annual wellness visit in one year. **S**

